Newron Pharmaceuticals SpA (NWRN) – Company Profile and SWOT Analysis
- Pages: 63
- Published: December 2025
- Report Code: MLPH82486FSA
Newron Pharmaceuticals SpA (NWRN) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Key Highlights
Newron Pharmaceuticals SpA (Newron) is a biopharmaceutical company. It focuses on the development of novel therapies for diseases of the central and peripheral nervous system. The company’s marketed the product, Xadago (safinamide), which is developed as an adjunctive therapy for any stage of Parkinson's disease. Newton's other products in the pipeline include ralfinamide for neuropathic pain and Evenamide (NW-3509) for the treatment of schizophrenia. The company's main activities include the research and development of innovative treatments for central nervous system disorders and pain management. It has development and commercialization collaborations with Zambon and Meiji Seika Pharma Co Ltd. The company has an international presence, with products approved in countries including Switzerland, the US, Australia, Canada, and Japan. Newron is headquartered in Bresso, Milan, Italy.
Scope
• Detailed information on Newron Pharmaceuticals SpA required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Newron Pharmaceuticals SpA in the form of a SWOT analysis
• An in-depth view of the business model of Newron Pharmaceuticals SpA including a breakdown and examination of key business segments
• News about Newron Pharmaceuticals SpA, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Newron Pharmaceuticals SpA and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Newron Pharmaceuticals SpA as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Newron Pharmaceuticals SpAs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Neurocrine Biosciences Inc
Santhera Pharmaceuticals Holding AG
Cerecin Pte Ltd
Silence Therapeutics Plc
AC Immune SA
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.